Stryker Corporation (SYK)
-NYSE | Prev Close: | 66.45 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 68.87 |
|---|
| Beta: | 0.94 |
|---|
| Next Earnings Date: | 18-Jul-13 |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 50.04 - 70.00 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 1,426,360 |
|---|
| Market Cap: | 25.12B |
|---|
| P/E (ttm): | 20.32 |
|---|
| EPS (ttm): | 3.27 |
|---|
| Div & Yield: | 1.06 (1.60%) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Stryker to Host Conference Call on July 18, 2013Thomson Reuters ONE(Wed, 19 Jun)
- Dividend Achievers for the Long Haul, Part 2at Motley Fool(Tue, 18 Jun)
- Positive Data for COV's SolitaireZacks(Tue, 18 Jun)
- Stryker Corp Director Sells 7K Shares and 4 Insider Sales to Noteat Wall St. Cheat Sheet(Mon, 17 Jun)
- Gloomy Prospects For Medical Device Companiesat Seeking Alpha(Sun, 16 Jun)
- Will Obamacare Deliver a Crushing Blow to the Middle Class?at Motley Fool(Sun, 16 Jun)
- Stryker Corporation Stock Buy Recommendation Reiterated (SYK)at TheStreet(Fri, 14 Jun)
- Should You Buy This Dividend Aristocrat?at Motley Fool(Fri, 14 Jun)
- U.S. FDA urges protection of medical devices from cyber threatsReuters(Fri, 14 Jun)
- U.S. FDA urges protection of medical devices from cyber threatsat Reuters(Fri, 14 Jun)
Key Statistics
| Forward P/E (1 yr): | 14.23 |
|---|
| P/S (ttm): | 2.89 |
|---|
| Ex-Dividend Date: | 26-Jun-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 4.29 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.03 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 1.92 |
|---|
Business Summary
Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities.
View More